Christopher J. Brereton
- Co-authors
- Mark G. JonesDonna E. DaviesJoshua S. DavisLuca RicheldiSophie FletcherAlexander GordonAiman AlzetaniFranco Conforti
- Topics
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (8 papers)Sarcoidosis and Beryllium Toxicity Research (4 papers)Eosinophilic Disorders and Syndromes (3 papers)
- Journals
- Cell Death and DiseaseInternational Journal of Antimicrobial AgentsJournal of Biomedical Optics
- Partner nations
- United KingdomItalyAustralia
In The Last Decade
Christopher J. Brereton
13 papers receiving 289 citations
Peers
Comparison fields: 5 of 63
- Pulmonary and Respiratory Medicine 165
- Surgery 63
- Epidemiology 57
- Molecular Biology 52
- Physiology 35
Countries citing papers authored by Christopher J. Brereton
This map shows the geographic impact of Christopher J. Brereton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher J. Brereton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher J. Brereton more than expected).
Fields of papers citing papers by Christopher J. Brereton
This network shows the impact of papers produced by Christopher J. Brereton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher J. Brereton. The network helps show where Christopher J. Brereton may publish in the future.
Co-authorship network of co-authors of Christopher J. Brereton
This figure shows the co-authorship network connecting the top 25 collaborators of Christopher J. Brereton. A scholar is included among the top collaborators of Christopher J. Brereton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher J. Brereton. Christopher J. Brereton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 22 | |
| 3 | 9 | |
| 4 | 4 | |
| 5 | 8 | |
| 6 | 18 | |
| 7 | 28 | |
| 8 | 2 | |
| 9 | 127 | |
| 10 | 1 | |
| 11 | 26 | |
| 12 | 7 | |
| 13 | 38 |
About Christopher J. Brereton
Christopher J. Brereton is a scholar working on Critical Care and Intensive Care Medicine, Pulmonary and Respiratory Medicine and Rheumatology, having authored 13 papers that have together received 291 indexed citations. Recurring topics across this work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (8 papers), Sarcoidosis and Beryllium Toxicity Research (4 papers) and Eosinophilic Disorders and Syndromes (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (165 citations), Biophysics (12 citations) and Epidemiology (57 citations). Christopher J. Brereton has collaborated with scholars based in United Kingdom, Italy and Australia. Frequent co-authors include Mark G. Jones, Donna E. Davies, Joshua S. Davis, Luca Richeldi, Sophie Fletcher, Alexander Gordon, Aiman Alzetani, Franco Conforti, Yihua Wang and Ben G. Marshall. Their work appears in journals such as Cell Death and Disease, International Journal of Antimicrobial Agents and Journal of Biomedical Optics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.